NDC 69097-421-19 - CELECOXIB
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69097-421
- Requested NDC
- 69097-421-19
- Package NDCs from labels
- 69097-421-07, 69097-421-12, 69097-421-02, 69097-421-19, 69097-421-21
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-07-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CELECOXIB - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-07-21 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - Medsource Pharmaceuticals | Cipla Limited- Kurkumbh | Medsource Pharmaceuticals | Cipla Limited- Kurkumbh | 2026-05-20 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - PD-Rx Pharmaceuticals, Inc. | PD-Rx Pharmaceuticals, Inc. | 2025-04-11 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - Cipla USA Inc. | CIPLA LIMITED KURKUMBH | CIPLA LIMITED INDORE | Cipla USA Inc. | CIPLA LIMITED KURKUMBH | CIPLA LIMITED INDORE | 2025-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2023-01-03 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - RedPharm Drug, Inc. | RedPharm Drug, Inc. | 2022-01-21 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - A-S Medication Solutions | A-S Medication Solutions | 2018-01-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69097-421-02 | CELECOXIB | 30 in 1 BOTTLE | CAPSULE | 30 | 14 | |
| 69097-421-07 | CELECOXIB | 100 in 1 BOTTLE | CAPSULE | 100 | 14 | |
| 69097-421-12 | CELECOXIB | 500 in 1 BOTTLE | CAPSULE | 500 | 14 | |
| 69097-421-19 | CELECOXIB | 10 in 1 BLISTER PACK | CAPSULE | 10 | 14 | |
| 69097-421-21 | CELECOXIB | 10 in 1 CARTON | CAPSULE | 10 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69097-421-07 | EA - Each | 69097-421 | c42aa30f-1dee-4eb3-bad6-220ead35de27 | 1 | 2016-04-04 |
| 69097-421-12 | EA - Each | 69097-421 | bb14d7e3-0d91-4d55-bc43-e2db9461b9e7 | 1 | 2016-04-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Celecoxib | CELECOXIB | Cardinal Health 107, LLC | a9114d6a-13d7-443c-be44-7866b4a4cf96 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| celecoxib | CELECOXIB | HAWAII REPACK, INC. | 45816eae-ad83-4d2f-a035-c3f9f24708f9 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | 686379 205323 349514 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | HAWAII REPACK, INC. | 77f3b90b-a25d-4c47-975a-2a988d696a3f | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | 686379 205323 349514 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | St Mary's Medical Park Pharmacy | e1ab644d-b668-3cf3-e053-2995a90addb0 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Radha Pharmaceuticals, Inc. | 2c86ece8-1cf5-4688-91b1-8aef5d60b7e4 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 686379 205323 349514 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Bryant Ranch Prepack | d94849a7-1831-4319-982c-c6b20dc42038 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| Rohto Sun and Sport | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 8bcc8882-b886-4b55-9bc4-d4b92a41358f | 2026-06-19 | Warnings | FZ989GH94E |
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | FZ989GH94E |
| celecoxib | CELECOXIB | PD-Rx Pharmaceuticals, Inc. | 78d59905-4a78-4d9f-ac29-58790a5b3a92 | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | FZ989GH94E |
| CELECOXIB | CELECOXIB | Bryant Ranch Prepack | fd569104-8243-48fa-8e93-5a08654ad6dd | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Redpharm Drug | 5250529a-6a03-78a1-e063-6294a90a47f9 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | PD-Rx Pharmaceuticals, Inc. | 52572bfb-43f0-4b55-b1fd-231a05c8b83e | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | AvPAK | 951df0f7-5fb7-40f5-e053-2995a90a1edd | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 205323 205322 JCX84Q7J1L |
| 5247da09-38c7-beb9-e063-6294a90a4b4c | 12140b38-10c0-74f6-e063-6294a90a5a46 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 5247da09-38c7-beb9-e063-6294a90a4b4c 12140b38-10c0-74f6-e063-6294a90a5a46 | ||
| celecoxib | CELECOXIB | Macleods Pharmaceuticals Limited | d14aecf5-16e9-459a-bda4-4ca8f290796a | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 686379 205323 349514 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | REMEDYREPACK INC. | 56d64558-1fad-420e-8fcd-7103cd073127 | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | ST. MARY'S MEDICAL PARK PHARMACY | ed2093f6-1606-100a-e053-2995a90a5b95 | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| iVIZIA Lubricant Eye Gel | POVIDONE | Thea Pharma Inc. | 1f06ca1a-5270-9a82-e063-6294a90aed64 | 2026-04-29 | Warnings | FZ989GH94E |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Preferred PHarmaceuticals Inc. | 011473a8-26d5-4661-b3c0-745f9b6aa1d8 | 2026-04-29 | Warnings | FZ989GH94E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.